Marion Flipo

1.6k total citations
30 papers, 962 citations indexed

About

Marion Flipo is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Marion Flipo has authored 30 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Marion Flipo's work include Tuberculosis Research and Epidemiology (11 papers), Cancer therapeutics and mechanisms (11 papers) and Biochemical and Molecular Research (7 papers). Marion Flipo is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Cancer therapeutics and mechanisms (11 papers) and Biochemical and Molecular Research (7 papers). Marion Flipo collaborates with scholars based in France, Belgium and United States. Marion Flipo's co-authors include Benoît Déprez, Nicolas Willand, Rebecca Deprez‐Poulain, Alain R. Baulard, Baptiste Villemagne, Céline Crauste, Isabelle Florent, Julie Charton, Florence Leroux and Catherine Piveteau and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Marion Flipo

30 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Flipo France 18 501 299 251 158 147 30 962
Alberto Venturelli Italy 18 306 0.6× 136 0.5× 198 0.8× 166 1.1× 89 0.6× 41 740
Marco Pieroni Italy 23 771 1.5× 493 1.6× 683 2.7× 332 2.1× 65 0.4× 58 1.6k
Christopher B. Cooper United States 21 684 1.4× 522 1.7× 502 2.0× 287 1.8× 70 0.5× 47 1.3k
Cecilia Pozzi Italy 18 536 1.1× 125 0.4× 171 0.7× 193 1.2× 120 0.8× 55 1.2k
Keiko Tabei United States 21 710 1.4× 161 0.5× 268 1.1× 75 0.5× 87 0.6× 32 1.2k
Vinayak Singh South Africa 21 559 1.1× 518 1.7× 263 1.0× 250 1.6× 49 0.3× 51 1.1k
Richard A. Stanton United States 12 343 0.7× 105 0.4× 212 0.8× 109 0.7× 120 0.8× 27 803
Jane A. Thanassi United States 21 658 1.3× 409 1.4× 245 1.0× 127 0.8× 54 0.4× 41 1.2k
Luciano Cellai Italy 21 676 1.3× 319 1.1× 215 0.9× 157 1.0× 53 0.4× 83 1.3k

Countries citing papers authored by Marion Flipo

Since Specialization
Citations

This map shows the geographic impact of Marion Flipo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Flipo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Flipo more than expected).

Fields of papers citing papers by Marion Flipo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Flipo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Flipo. The network helps show where Marion Flipo may publish in the future.

Co-authorship network of co-authors of Marion Flipo

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Flipo. A scholar is included among the top collaborators of Marion Flipo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Flipo. Marion Flipo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piveteau, Catherine, Florence Leroux, Stéphanie Slupek, et al.. (2023). Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals. 16(3). 335–335. 2 indexed citations
2.
Jiménez-Castellanos, Juan-Carlos, Elizabeth Pradel, Catherine Piveteau, et al.. (2023). Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump. European Journal of Medicinal Chemistry. 259. 115630–115630. 6 indexed citations
3.
Hartkoorn, Ruben C., et al.. (2023). Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria. Antibiotics. 12(1). 180–180. 69 indexed citations
4.
Jiménez-Castellanos, Juan-Carlos, et al.. (2023). Characterization of pyridylpiperazine-based efflux pump inhibitors for Acinetobacter baumannii. JAC-Antimicrobial Resistance. 5(5). dlad112–dlad112. 5 indexed citations
5.
Jiménez-Castellanos, Juan-Carlos, Laurye Van Maele, Elizabeth Pradel, et al.. (2023). Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Molecular Medicine. 16(1). 93–111. 12 indexed citations
6.
Flipo, Marion, et al.. (2023). Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance. European Journal of Medicinal Chemistry. 256. 115413–115413. 24 indexed citations
7.
Piveteau, Catherine, Frédéric Capet, Michel Marion, et al.. (2023). Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers’ Lactamization. Pharmaceuticals. 16(3). 413–413. 1 indexed citations
8.
Plé, Coline, Heng-Keat Tam, Juan-Carlos Jiménez-Castellanos, et al.. (2022). Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nature Communications. 13(1). 115–115. 46 indexed citations
9.
Hamela, Claire, Rudy Antoine, Adrien Herlédan, et al.. (2022). Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases. Journal of Medicinal Chemistry. 65(24). 16651–16664. 14 indexed citations
10.
Déprez, Benoît, Damien Bosc, Julie Charton, et al.. (2021). Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal Chemistry. Molecules. 26(19). 6083–6083. 2 indexed citations
11.
Kemmer, Christian, Adrien Herlédan, Rosangela Frita, et al.. (2019). A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. European Journal of Medicinal Chemistry. 167. 426–438. 14 indexed citations
12.
Wohlkönig, Alexandre, Sameh H. Soror, Marion Flipo, et al.. (2018). A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1867(3). 248–258. 11 indexed citations
13.
Flipo, Marion, Niël van Wyk, Albertus Viljoen, et al.. (2018). Structural rearrangements occurring upon cofactor binding in the Mycobacterium smegmatis β-ketoacyl-acyl carrier protein reductase MabA. Acta Crystallographica Section D Structural Biology. 74(5). 383–393. 4 indexed citations
14.
Pancani, Elisabetta, Samuel Jouny, Arnaud Machelart, et al.. (2017). Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. Scientific Reports. 7(1). 5390–5390. 67 indexed citations
15.
Crauste, Céline, Nicolas Willand, Baptiste Villemagne, et al.. (2014). Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligands. Analytical Biochemistry. 452. 54–66. 20 indexed citations
16.
Charton, Julie, Qing Guo, Nathalie Hennuyer, et al.. (2014). Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis. European Journal of Medicinal Chemistry. 79. 184–193. 24 indexed citations
17.
Villemagne, Baptiste, Céline Crauste, Marion Flipo, et al.. (2012). Tuberculosis: The drug development pipeline at a glance. European Journal of Medicinal Chemistry. 51. 1–16. 136 indexed citations
18.
Flipo, Marion, Terence Beghyn, Vincent Leroux, et al.. (2007). Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents. Journal of Medicinal Chemistry. 50(6). 1322–1334. 60 indexed citations
19.
Flipo, Marion, Terence Beghyn, Julie Charton, et al.. (2006). A library of novel hydroxamic acids targeting the metallo-protease family: Design, parallel synthesis and screening. Bioorganic & Medicinal Chemistry. 15(1). 63–76. 29 indexed citations
20.
Flipo, Marion, Isabelle Florent, Philippe Grellier, Christian Sergheraert, & Rebecca Deprez‐Poulain. (2003). Design, synthesis and antimalarial activity of novel, quinoline-Based, zinc metallo-aminopeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(16). 2659–2662. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Venturelli Breakdown of academic impact, for papers by Marco Pieroni Breakdown of academic impact, for papers by Christopher B. Cooper Breakdown of academic impact, for papers by Cecilia Pozzi Breakdown of academic impact, for papers by Keiko Tabei Breakdown of academic impact, for papers by Vinayak Singh Breakdown of academic impact, for papers by Richard A. Stanton Breakdown of academic impact, for papers by Jane A. Thanassi Breakdown of academic impact, for papers by Luciano Cellai
Rankless by CCL
2026